Jan 17, 2022 07:30AM
Dec 21, 2021 07:15AM
Apr 21, 2021 05:00AM
Apr 14, 2021 01:51PM
Apr 1, 2021 08:30AM
Mar 17, 2021 08:30AM
Mar 12, 2021 08:30AM Claritas Announces Completion of IND-Enabling Rodent Toxicology Studies with R-107
Jul 16, 2020 07:30AM
Jun 30, 2020 02:22PM
Jun 16, 2020 07:00AM
Jun 15, 2020 07:30AM
Jun 9, 2020 07:00AM
Jun 5, 2020 07:00AM
Jun 2, 2020 07:00AM Kalytera Announces Filing of Provisional Patent Protecting Use of R-107 for Treatment of Coronavirus and COVID-19 Associated Pneumonia
May 29, 2020 08:00AM
May 25, 2020 07:00AM
May 19, 2020 08:30AM
Mar 16, 2020 08:00AM
Nov 22, 2019 08:30AM
Oct 2, 2019 08:30AM
Aug 19, 2019 08:00AM Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study
Jul 16, 2019 08:30AM
Jun 27, 2019 08:30AM
Jun 25, 2019 09:54AM
Jun 18, 2019 08:30AM
May 28, 2019 08:30AM
May 21, 2019 04:42PM
May 21, 2019 09:00AM Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products
Mar 22, 2019 07:30AM
Mar 6, 2019 07:30AM
Feb 5, 2019 07:30AM
Dec 20, 2018 12:10PM
Dec 20, 2018 07:37AM
Dec 20, 2018 07:30AM
Sep 20, 2018 07:30AM Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD
Aug 2, 2018 08:00AM
Jul 5, 2018 07:30AM
Jun 21, 2018 07:30AM
Apr 26, 2018 09:00AM
Apr 19, 2018 07:30AM
Apr 13, 2018 09:00AM
Nov 27, 2017 07:30AM Kalytera Announces Second US Patent for Prevention and Treatment of Graft Versus Host Disease
Nov 15, 2017 07:30AM
Oct 10, 2017 07:58PM

329,074 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All